PDGFB and central nervous system cancer: We performed Kaplan-Meier survival analysis of human glioma samples from The Cancer Genome Atlas (TCGA) and found that high expression of PDGFB independently predicts worse survival outcomes in mIDH glioma but has no effect on overall survival in IDH wild-type (wtIDH) glioma (Figs. S1a–b).